The Exclusive Home of Pharmapreneurship™
The University of Maryland School of Pharmacy globally engages and leads education, pharmacy practice, scientific research, and pharmapreneurial initiatives to collaboratively and equitably improve the health of society.
What is Pharmapreneurism?
Learn more about pharmapreneurism at the School of Pharmacy, and how this innovative initiative is being used to advance pharmacy education, scientific discovery, patient care, and community engagement across the state of Maryland and beyond.
We are internationally recognized for:
- empowering learners and graduating visionary leaders
- pioneering social impact and business innovation through Pharmapreneurship
- listening to all voices to equitably enrich the lives of our internal and external communities
- positively influencing the delivery of convenient and affordable health care
- leveraging pharmaceutical expertise and relentlessly collaborating to solve scientific, clinical, and social problems that matter to all citizens of the world
Pharmapreneurship is the University of Maryland School of Pharmacy’s commitment to supporting and best positioning both faculty and students to achieve their career aspirations and address our nation’s health care challenges.
Research
- #9 in funded research grants out of more than 140 schools of pharmacy in the country by AACP
- $38.5 million in 2022 — NIH, NSF, FDA, CDC, Agency for Healthcare Research and Quality, PhRMA Foundation, and the pharmaceutical industry
- $50 million — five-year renewal of the Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) by the FDA
- $46 million — Center for Translational Medicine is co-PI on grant from the Defense Advanced Research Projects Agency to create an artificial blood product
- $5 million — FDA funding for the Center for Research on Complex Generics in partnership with the University of Michigan College of Pharmacy
Major Leadership Bequest
The University of Maryland School of Pharmacy has received an eight-figure leadership bequest to propel Pharmapreneurship, education, research, practice, and service - the largest single donation from an individual in the history of the University of Maryland, Baltimore.
Practice and Community Engagement
- $10 million contract from the state of Maryland for pharmacy services at state mental health facilities and to oversee review of mental health medications for children on Medicaid.
- Center for Innovative Pharmacy Solutions’ (CIPS) E-Health Center provides comprehensive medication management services to health systems, physicians’ offices, and insurers through a HIPAA-compliant app and telehealth and telephonic platforms.
- $5 million contract to CIPS from physicians’ offices and health care systems to embed pharmacists in primary care practices under the Centers for Medicare and Medicaid Services’ unique Maryland Primary Care Program.
- Peter Lamy Center on Drug Therapy and Aging improves the lives of older adults by optimizing medication safety and use through practice, research, and education, and a leader within the University of Maryland, Baltimore’s Age-Friendly University initiative.
- PATIENTS Program boasts an interdisciplinary team of community partners and researchers working for health equity in West Baltimore by engaging underserved populations.
- Maryland Poison Center — 50 years, 2.5 million calls handled by pharmacists and nurses with more than 210 years of combined experience.
Education
- $1 million gift for the Felix A. Khin Maung-Gyi, BSP ’83, PharmD, MBA, Endowed Memorial Professorship in Pharmapreneurship
- $30,000 Gyi Scholarship — a full year of tuition for a pharmacy student who has demonstrated a commitment to pharmapreneurship. Largest scholarship in School history.
- $100,000 Natalie D. Eddington Pharmapreneurship Award for Health Care Innovation for pharmacy student pitch competition, the largest award of its kind nationally.
- Nine $10,000 Wagner Scholarships — awarded to students in the Pharmapreneurship pathway, providing a platform to explore business ideas and ventures.
- Pharmapreneurship Pathway — selective curricular opportunity for pharmacy students to pursue special interests in innovation, entrepreneurism, and creativity
- $1.1 million NIH grant for Initiative for Maximizing Student Development to increase the number of students from underrepresented groups in UMSOP’s PhD in Pharmaceutical Sciences program and the School of Medicine’s Graduate Program in Life Sciences program.
- MS in Pharmaceutical Sciences — every student completes a six-month biopharmaceutical internship in the pharmaceutical industry, including at AstraZeneca and the National Institute of Standards and Technology, leading to employment opportunities.
- Innovative and diverse academic programs for PharmD students to customize their degrees to achieve their career goals: one PharmD, three PhDs, six MS, 10 dual degrees
- 2023 APhA-ASP National Chapter of the Year Award — first win in School history for chapter’s work in patient care outreach, education, and awareness
- Home of the nation’s first MS in Medical Cannabis Science and Therapeutics, with nearly 500 graduates in the program’s first three years.
- Alumni Impact — More than 7,000 alumni; founders of companies such as CorrectRx Pharmacy Services, Pricklee Cactus Water, OneWorld Health, Medicines360, Merck Sharpe and Dohme, Noxell Corporation, Nutramax Labs, and King Pharmaceuticals